HUE055368T2 - Vérzéscsillapító folyadék - Google Patents

Vérzéscsillapító folyadék

Info

Publication number
HUE055368T2
HUE055368T2 HUE17749493A HUE17749493A HUE055368T2 HU E055368 T2 HUE055368 T2 HU E055368T2 HU E17749493 A HUE17749493 A HU E17749493A HU E17749493 A HUE17749493 A HU E17749493A HU E055368 T2 HUE055368 T2 HU E055368T2
Authority
HU
Hungary
Prior art keywords
hemostatic flowable
hemostatic
flowable
Prior art date
Application number
HUE17749493A
Other languages
English (en)
Inventor
William Spotnitz
Valerie Centis
Campos Doris Moura
Gasperis Alexia De
Original Assignee
Biomup France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomup France Sas filed Critical Biomup France Sas
Publication of HUE055368T2 publication Critical patent/HUE055368T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
HUE17749493A 2016-08-12 2017-08-11 Vérzéscsillapító folyadék HUE055368T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16184119 2016-08-12

Publications (1)

Publication Number Publication Date
HUE055368T2 true HUE055368T2 (hu) 2021-11-29

Family

ID=56684537

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17749493A HUE055368T2 (hu) 2016-08-12 2017-08-11 Vérzéscsillapító folyadék

Country Status (14)

Country Link
US (1) US11052172B2 (hu)
EP (1) EP3496770B1 (hu)
JP (1) JP7039559B2 (hu)
CN (1) CN110087697A (hu)
AU (1) AU2017310470B2 (hu)
BR (1) BR112019001894B1 (hu)
CA (1) CA3032657A1 (hu)
DK (1) DK3496770T3 (hu)
ES (1) ES2882506T3 (hu)
HU (1) HUE055368T2 (hu)
IL (1) IL264716B (hu)
PL (1) PL3496770T3 (hu)
PT (1) PT3496770T (hu)
WO (1) WO2018029340A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US20230119502A1 (en) * 2020-03-30 2023-04-20 Northeastern University Collagen Nucleation Inhibitors
CN114681658B (zh) * 2020-12-31 2023-03-14 广州迈普再生医学科技股份有限公司 纤维聚集体及其制备方法和应用
CN114288463B (zh) * 2021-12-13 2022-07-05 鹏拓生物科技(杭州)有限公司 一种流体胶原蛋白止血材料的研制方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13810T1 (de) 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
US4515637A (en) 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US4942153A (en) 1987-02-03 1990-07-17 Fernandez Helen M Skin moisturizing product and process
US5263984A (en) 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US5413571A (en) * 1992-07-16 1995-05-09 Sherwood Medical Company Device for sealing hemostatic incisions
IT1263394B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
DE19520575A1 (de) 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
AU7977298A (en) 1997-06-18 1999-01-04 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof
US20050208114A1 (en) 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
HUP0104168A3 (en) 1998-08-20 2003-04-28 3M Innovative Properties Co Spray on bandage and drug delivery system
WO2001097826A2 (en) * 2000-06-16 2001-12-27 University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
AT412445B (de) 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
AT411326B (de) 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
CN2442681Y (zh) * 2000-08-18 2001-08-15 刘高东 药用喷雾罐
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030003157A1 (en) 2001-06-06 2003-01-02 University Of Medicine & Dentistry Of New Jersey Collagen compositions and methods for making and using the same
JP3805654B2 (ja) 2001-08-29 2006-08-02 株式会社ネクスト 止血・癒着防止性のバイオポリマーの微細粒子
WO2003026709A1 (en) 2001-09-26 2003-04-03 Mbs Multination Business Services (G.B.) Ltd. Liquid mixture for use as a dressing spray
JP4668510B2 (ja) * 2001-09-29 2011-04-13 持田製薬株式会社 可撓性容器入り局所止血用医薬組成物
KR101036696B1 (ko) * 2001-12-21 2011-05-24 훼로산 메디칼 디바이스 에이/에스 지혈 키트, 지혈제의 제조 방법 및 지혈을 촉진하는 방법
EP1501558A1 (de) 2002-05-08 2005-02-02 Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) Resorbierbare pharmazeutische formulierung zur kontinuierlichen thrombinfreisetzung
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20060019868A1 (en) * 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
US8153591B2 (en) 2003-08-26 2012-04-10 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
CN1554448A (zh) 2003-12-23 2004-12-15 张淑荣 壳聚糖明胶聚乙烯醇生物止血敷料
JP2007519450A (ja) * 2004-01-30 2007-07-19 フェロサン アー／エス 止血用のスプレーおよび組成物
WO2005087182A1 (ja) 2004-03-17 2005-09-22 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 機能性粉体
EP1580229A1 (en) 2004-03-22 2005-09-28 Warner-Lambert Company Llc Biopolymer compositons and products thereof
EP1745747A4 (en) 2004-05-13 2010-12-29 Next21 Kk DEVICE FOR HEMOSTASIS AND PREVENTION OF ADHESIONS FOR USE IN ENDOSCOPIC SURGERY
CA2571981C (en) 2004-07-09 2014-12-30 Ferrosan A/S Haemostatic composition comprising hyaluronic acid
US7429386B2 (en) * 2004-09-03 2008-09-30 Allergan, Inc. Stretch mark treatment
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN1709507A (zh) 2005-06-29 2005-12-21 肖春 外用复方止血镇痛消炎药
CN101272790A (zh) 2005-09-22 2008-09-24 特罗比奥股份公司 稳定的蛋白酶组合物
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
EP2219572A4 (en) 2007-12-06 2014-05-28 Nanosys Inc RESORBABLE HEMOSTATIC STRUCTURES ENHANCED BY NANOMATERIAL AND BANDING MATERIALS
AU2009220808B2 (en) 2008-03-03 2014-01-16 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
AU2010229861A1 (en) * 2009-03-27 2011-10-20 Johnson & Johnson Consumer Companies, Inc. Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
FR2944706B1 (fr) 2009-04-28 2012-08-24 Biom Up Nouveaux materiaux en collagene et procedes d'obtention.
CN101757614B (zh) 2010-02-22 2012-04-04 苏州汇涵医用科技发展有限公司 止血剂及其制备方法
CN101837143A (zh) 2010-04-22 2010-09-22 胡堃 一种药物缓释止血组合物及制备方法
WO2012122044A2 (en) 2011-03-04 2012-09-13 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
CA3108894A1 (en) 2011-04-27 2012-11-01 Biom'up Hemostatic compositions
US9555185B2 (en) * 2011-04-27 2017-01-31 Biom'up Biomedical haemostatic powder dispenser
US9724078B2 (en) * 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CN105769554A (zh) * 2014-12-23 2016-07-20 天津博众纳德生物科技有限公司 带有两翼的可吸收止血粉的瓶子

Also Published As

Publication number Publication date
US20190167840A1 (en) 2019-06-06
ES2882506T3 (es) 2021-12-02
DK3496770T3 (da) 2021-06-21
RU2019105215A (ru) 2020-09-14
NZ750516A (en) 2023-10-27
PT3496770T (pt) 2021-08-10
US11052172B2 (en) 2021-07-06
BR112019001894B1 (pt) 2022-06-14
BR112019001894A2 (pt) 2019-05-07
RU2019105215A3 (hu) 2020-10-09
AU2017310470A1 (en) 2019-02-28
EP3496770B1 (en) 2021-05-19
WO2018029340A1 (en) 2018-02-15
CA3032657A1 (en) 2018-02-15
AU2017310470B2 (en) 2021-12-16
JP2019524313A (ja) 2019-09-05
EP3496770A1 (en) 2019-06-19
CN110087697A (zh) 2019-08-02
PL3496770T3 (pl) 2021-09-27
JP7039559B2 (ja) 2022-03-22
IL264716B (en) 2021-09-30

Similar Documents

Publication Publication Date Title
SG11201704537QA (en) Flowable hemostatic composition
IL259203B (en) Hemostatic drug
IL264716B (en) Hemostatic flowable
GB201608319D0 (en) Mixer unit
PT3474858T (pt) Composição de dois componentes que compreende ácido acetilsalicílico
ZA201904529B (en) Mixer
GB201600075D0 (en) Immunogenci composition
IL271469A (en) Hemostatic products
ZA201901222B (en) Composition comprising duddingtonia flagrans
GB201612658D0 (en) Composition
GB201612359D0 (en) Composition
GB201611782D0 (en) Composition
GB201617908D0 (en) Composition
GB201615908D0 (en) Pharmaceautical composition
GB201607924D0 (en) Composition
GB201620792D0 (en) Composition
GB201619630D0 (en) Composition
GB201618062D0 (en) Composition
GB201616785D0 (en) Composition
GB201616772D0 (en) Composition
GB201616654D0 (en) Composition
GB201615463D0 (en) Composition
GB201615461D0 (en) Composition
GB201615383D0 (en) Composition
GB201615045D0 (en) Composition